Categories Earnings, Technology

Uber’s loss continues in Q3, revenue and bookings increase

Uber, which is set to become a public company in 2019, reported its results for the third quarter of 2018. Uber once again reported a loss for the quarter, hurt by the new business investments. Net loss, on an adjusted basis, stretched to $939 million from $659 million in the second quarter. On a GAAP basis, net loss stood at $1.07 billion.

Uber Q3 2018 earnings
Image Courtesy: Wikimedia Commons

Even though revenue rose 38% year-over-year to $2.95 billion, this indicates a slow growth compared to the growth of 67% and 60% in Q1 2018 and Q2 2018, respectively. Gross bookings increased 34% annually to $12.7 billion. UberEats’ gross bookings stood at $2.1 billion, up more than 150% in the prior year quarter.

Adjusted EBITDA loss for the recently ended quarter was $527 million, down 13% from the year-ago period. The ride-hailing company’s gross cash declined to $6.55 billion from $7.3 billion at the end of the second quarter.

Nelson Chai, who was appointed as the CFO in August, said, “As we look ahead to an IPO and beyond, we are investing in future growth across our platform, including in food, freight, electric bikes and scooters, and high-potential markets in India and the Middle East where we continue to solidify our leadership position.”

Uber’s Q2 revenue and bookings increase YoY

Like the rival Lyft, the San Francisco-based firm announced a rewards program, Uber Rewards, for its ride-hailing and food delivery business on Wednesday. Through this rewards program, Uber will offer perks to its loyal customers such as cash back on rides and priority pickups.

On October 2, the Dara Khosrowshahi-led firm appointed Nikki Krishnamurthy as its Chief People Officer. Before joining Uber, she served as Chief People Officer in Expedia Inc (EXPE).

 

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

What to expect when J.M. Smucker (SJM) reports Q2 2025 earnings results

Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Friday. The stock has dropped 6% over the past three months. The branded foods company is slated to report

Earnings Summary: Highlights of BJ’s Wholesale Club’s Q3 2024 results

Department store chain BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has reported financial results for the third quarter of 2024, reporting a 3% increase in net sales. Adjusted earnings, on a

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top